查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1613338

糖尿病足溃疡治疗市场：治疗方法、溃疡类型和最终用途分类 - 全球预测 2025-2030

Diabetic Foot Ulcer Treatment Market by Treatment (Antibiotic Medications, Biologics, Therapy Devices), Ulcer Type (Ischemic Ulcers, Neuro-Ischemic Ulcers, Neuropathic Ulcers), End-use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年糖尿病足溃疡治疗市场规模为53.5亿美元，预计2024年将达56.9亿美元，复合年增长率为6.56%，预计2030年将达83.5亿美元。

糖尿病足溃疡治疗市场包括一系列旨在管理和治疗糖尿病患者足部溃疡的产品和服务。这包括先进的创伤护理解决方案，如敷料、移植物和负压伤口护理，以及药品，如蛋白酶抑制剂和抗生素治疗。由于全世界糖尿病盛行率不断增加，因此需要这些治疗。由于血液循环不良和神经病变，糖尿病会增加足部溃疡的风险，如果不治疗，可能会导致严重感染疾病和截肢。应用范围广泛，从医院、诊所到居家医疗，最终用途主要针对医疗机构和个人患者。影响成长的关键因素包括伤口护理技术的进步、患者对糖尿病併发症严重性的认识提高以及政府改善糖尿病护理的努力。机会包括个人化医疗方法以及人工智慧和物联网的整合以远端监测和管理溃疡。建议包括投资生物分解性和生物工程创伤护理产品的研发，并探索技术整合的伙伴关係。然而，市场成长面临治疗成本高和缺乏熟练医疗保健专业人员等挑战，特别是在低收入地区。监管障碍和报销问题使市场动态更加复杂。创新机会在于远端医疗平台的开发，这些平台可以提高患者的依从性，并提供具有成本效益的解决方案，以扩大新兴国家的服务范围。该市场既竞争分散又协作，其特点是不断的技术进步和主要企业之间的策略联盟以共用专业知识。注重平衡有效性和可负担性的以患者为中心的解决方案将推动持续成长，特别是在鼓励创新和减少市场进入障碍的政策框架的支持下。

主要市场统计
基准年[2023] 53.5亿美元
预计年份 [2024] 56.9亿美元
预测年份 [2030] 83.5亿美元
复合年增长率（%） 6.56%

市场动态：快速发展的糖尿病足溃疡治疗市场的关键市场洞察

供需的动态交互作用正在改变糖尿病足溃疡治疗市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 老年族群糖尿病足溃疡盛行率增加
    • 提高医疗保健专业人员对有效 DPU 管理的认识
  • 市场限制因素
    • 先进伤口护理设备和治疗方法高成本
  • 市场机会
    • 继续积极引进新药治疗糖尿病足溃疡
    • 扩大开发具有成本效益的糖尿病足溃疡预防解决方案
  • 市场挑战
    • 糖尿病足溃疡的有限报销政策

波特五力：驾驭糖尿病足溃疡治疗市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解糖尿病足溃疡治疗市场的外部影响

外部宏观环境因素在塑造糖尿病足溃疡治疗市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解糖尿病足溃疡治疗市场的竞争格局

对糖尿病足溃疡治疗市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵糖尿病足溃疡治疗市场供应商的绩效评估

FPNV 定位矩阵是评估糖尿病足溃疡治疗市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议绘製糖尿病足溃疡治疗市场的成功之路

对于希望加强在全球市场的影响力的公司来说，对糖尿病足溃疡治疗市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 老年人糖尿病足溃疡盛行率增加
      • 医护人员对有效 DPU 管理的认识正在增强
    • 抑制因素
      • 先进伤口护理设备和治疗方法高成本
    • 机会
      • 正在推出治疗糖尿病足溃疡的新治疗方法
      • 预防糖尿病足溃疡的经济高效解决方案的开发进展
    • 任务
      • 糖尿病足溃疡的报销政策有限
  • 市场区隔分析
    • 治疗：透过创伤护理敷料和治疗设备的创新来优化护理并改善患者的治疗效果。
    • 最终用途：将低成本、先进的 DFU 治疗扩展到全医院范围内
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章糖尿病足溃疡治疗市场（依治疗）

  • 抗生素
  • 生物製药
    • 生长因子
    • 植皮
  • 治疗设备
    • 负压伤口治疗法
    • 超音波治疗
  • 创伤护理敷料
    • 藻酸盐敷料
    • 膜敷料
    • 泡棉敷料
    • 亲水胶体敷料
    • 亲水性纤维敷料敷料
    • 水凝胶敷料
    • 手术绷带

第七章按溃疡类型分類的糖尿病足溃疡治疗市场

  • 缺血性溃疡
  • 神经缺血性溃疡
  • 神经病变溃疡

第八章糖尿病足溃疡治疗市场：依最终用途分类

  • 门诊影像中心
  • 医院

第九章北美和南美糖尿病足溃疡治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区糖尿病足溃疡治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲糖尿病足溃疡治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 研究人员开发 3D 列印绷带作为糖尿病足溃疡的创新治疗方法
    • Healthium 推出 Theruptor Novo，一种治疗糖尿病足溃疡的药物
    • 施乐辉 (Smith-Nephew) 发表的新研究表明，与竞争产品相比，GRAFIX 膜可将糖尿病足溃疡復发率降低一半。
    • Alkem Laboratories 宣布推出糖尿病足溃疡管理技术
  • 战略分析和建议

公司名单

  • 3M Company
  • Adocia SA
  • Alkem Laboratories Ltd.
  • B. Braun SE
  • Cardinal Health, Inc.
  • Centaur Pharmaceuticals Private Limited
  • Cipla Limited
  • Coloplast Corp.
  • ConvaTec, Inc.
  • Essity AB
  • GlaxoSmithKline PLC
  • Healthium Medtech Limited
  • Integra LifeSciences Corporation
  • Medline Industries, Inc.
  • MIMEDX, Inc.
  • Molnlycke Health Care AB
  • Organogenesis, Inc.
  • PAUL HARTMANN AG
  • Pristyn Care
  • Reapplix A/S
  • SANUWAVE Health, Inc.
  • SIGVARIS Group
  • Smith & Nephew PLC
  • SynerHeal Pharmaceuticals
  • Tissue Regenix Ltd.
  • URGO Medical, Australia Pty Ltd.
Product Code: MRR-F927BA462A59

The Diabetic Foot Ulcer Treatment Market was valued at USD 5.35 billion in 2023, expected to reach USD 5.69 billion in 2024, and is projected to grow at a CAGR of 6.56%, to USD 8.35 billion by 2030.

The diabetic foot ulcer treatment market encompasses a broad range of products and services aimed at managing and healing foot ulcers in diabetic patients. This includes both advanced wound care solutions such as dressings, grafts, and negative pressure wound therapy, as well as pharmaceuticals like protease inhibitors and antibiotic treatments. The necessity for these treatments arises from the increasing global prevalence of diabetes, which heightens the risk of foot ulcers due to poor circulation and neuropathy, leading to the potential for severe infections and amputations if untreated. Applications span from hospital and in-clinic environments to home healthcare settings, with end-use primarily involving healthcare institutions and individual patients. Key factors influencing growth include advancements in wound care technologies, rising awareness among patients regarding the severity of diabetic complications, and government initiatives to improve diabetic care. On the opportunity front, the market offers potential in personalized medicine approaches and the integration of AI and IoT for remote monitoring and management of ulcers. Recommendations include investing in R&D for biodegradable and bioengineered wound care products and exploring partnerships for technology integration. However, market growth faces challenges such as high treatment costs, particularly in low-income regions, and the lack of skilled healthcare professionals. Regulatory barriers and reimbursement issues further complicate market dynamics. Innovation opportunities lie in telemedicine platforms for better patient compliance and developing cost-effective solutions to expand access in developing countries. The market is competitively fragmented yet collaborative, characterized by constant technological advancements and strategic alliances among key players to leverage shared expertise. Focus on patient-centric solutions that balance effectiveness with affordability can drive sustained growth, particularly if supported by policy frameworks that encourage innovation and reduce barriers to market entry.

KEY MARKET STATISTICS
Base Year [2023] USD 5.35 billion
Estimated Year [2024] USD 5.69 billion
Forecast Year [2030] USD 8.35 billion
CAGR (%) 6.56%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Diabetic Foot Ulcer Treatment Market

The Diabetic Foot Ulcer Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of diabetic foot ulcers among the geriatric population
    • Rising awareness about effective DPU management among healthcare professionals
  • Market Restraints
    • High cost of advanced wound care devices and therapies
  • Market Opportunities
    • Ongoing introduction of new active diabetic foot ulcer therapies
    • Growing development of cost-effective solutions for diabetic foot ulcer prevention
  • Market Challenges
    • Limited availability of reimbursement policies for diabetic foot ulcers

Porter's Five Forces: A Strategic Tool for Navigating the Diabetic Foot Ulcer Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Diabetic Foot Ulcer Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Diabetic Foot Ulcer Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Diabetic Foot Ulcer Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Diabetic Foot Ulcer Treatment Market

A detailed market share analysis in the Diabetic Foot Ulcer Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Diabetic Foot Ulcer Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Diabetic Foot Ulcer Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Diabetic Foot Ulcer Treatment Market

A strategic analysis of the Diabetic Foot Ulcer Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Diabetic Foot Ulcer Treatment Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Adocia SA, Alkem Laboratories Ltd., B. Braun SE, Cardinal Health, Inc., Centaur Pharmaceuticals Private Limited, Cipla Limited, Coloplast Corp., ConvaTec, Inc., Essity AB, GlaxoSmithKline PLC, Healthium Medtech Limited, Integra LifeSciences Corporation, Medline Industries, Inc., MIMEDX, Inc., Molnlycke Health Care AB, Organogenesis, Inc., PAUL HARTMANN AG, Pristyn Care, Reapplix A/S, SANUWAVE Health, Inc., SIGVARIS Group, Smith & Nephew PLC, SynerHeal Pharmaceuticals, Tissue Regenix Ltd., and URGO Medical, Australia Pty Ltd..

Market Segmentation & Coverage

This research report categorizes the Diabetic Foot Ulcer Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Treatment, market is studied across Antibiotic Medications, Biologics, Therapy Devices, and Wound Care Dressings. The Biologics is further studied across Growth Factors and Skin Grafts. The Therapy Devices is further studied across Negative Pressure Wound Therapy and Ultrasound Therapy. The Wound Care Dressings is further studied across Alginate Dressings, Film Dressing, Foam Dressings, Hydrocolloid Dressings, Hydrofiber Dressings, Hydrogel Dressings, and Surgical Dressings.
  • Based on Ulcer Type, market is studied across Ischemic Ulcers, Neuro-Ischemic Ulcers, and Neuropathic Ulcers.
  • Based on End-use, market is studied across Ambulatory Imaging Center and Hospital.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of diabetic foot ulcers among the geriatric population
      • 5.1.1.2. Rising awareness about effective DPU management among healthcare professionals
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of advanced wound care devices and therapies
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing introduction of new active diabetic foot ulcer therapies
      • 5.1.3.2. Growing development of cost-effective solutions for diabetic foot ulcer prevention
    • 5.1.4. Challenges
      • 5.1.4.1. Limited availability of reimbursement policies for diabetic foot ulcers
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Treatment: Innovations in wound care dressings and therapy devices to optimize care and improve patient outcomes
    • 5.2.2. End-Use: Expanding availability of low-cost and advanced DFU treatments across hospitals
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Diabetic Foot Ulcer Treatment Market, by Treatment

  • 6.1. Introduction
  • 6.2. Antibiotic Medications
  • 6.3. Biologics
    • 6.3.1. Growth Factors
    • 6.3.2. Skin Grafts
  • 6.4. Therapy Devices
    • 6.4.1. Negative Pressure Wound Therapy
    • 6.4.2. Ultrasound Therapy
  • 6.5. Wound Care Dressings
    • 6.5.1. Alginate Dressings
    • 6.5.2. Film Dressing
    • 6.5.3. Foam Dressings
    • 6.5.4. Hydrocolloid Dressings
    • 6.5.5. Hydrofiber Dressings
    • 6.5.6. Hydrogel Dressings
    • 6.5.7. Surgical Dressings

7. Diabetic Foot Ulcer Treatment Market, by Ulcer Type

  • 7.1. Introduction
  • 7.2. Ischemic Ulcers
  • 7.3. Neuro-Ischemic Ulcers
  • 7.4. Neuropathic Ulcers

8. Diabetic Foot Ulcer Treatment Market, by End-use

  • 8.1. Introduction
  • 8.2. Ambulatory Imaging Center
  • 8.3. Hospital

9. Americas Diabetic Foot Ulcer Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Diabetic Foot Ulcer Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Diabetic Foot Ulcer Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Researchers develop 3D printed bandage that delivers innovative treatment for diabetic foot ulcers
    • 12.3.2. Healthium launches Theruptor Novo for diabetic foot ulcers
    • 12.3.3. Smith+Nephew announces new study showing GRAFIX Membrane cut the rate of diabetic foot ulcer recurrence in half compared to competitors
    • 12.3.4. Alkem Laboratories Announces Launch of Technology For Diabetic Foot Ulcer Management
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Adocia SA
  • 3. Alkem Laboratories Ltd.
  • 4. B. Braun SE
  • 5. Cardinal Health, Inc.
  • 6. Centaur Pharmaceuticals Private Limited
  • 7. Cipla Limited
  • 8. Coloplast Corp.
  • 9. ConvaTec, Inc.
  • 10. Essity AB
  • 11. GlaxoSmithKline PLC
  • 12. Healthium Medtech Limited
  • 13. Integra LifeSciences Corporation
  • 14. Medline Industries, Inc.
  • 15. MIMEDX, Inc.
  • 16. Molnlycke Health Care AB
  • 17. Organogenesis, Inc.
  • 18. PAUL HARTMANN AG
  • 19. Pristyn Care
  • 20. Reapplix A/S
  • 21. SANUWAVE Health, Inc.
  • 22. SIGVARIS Group
  • 23. Smith & Nephew PLC
  • 24. SynerHeal Pharmaceuticals
  • 25. Tissue Regenix Ltd.
  • 26. URGO Medical, Australia Pty Ltd.

LIST OF FIGURES

  • FIGURE 1. DIABETIC FOOT ULCER TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. DIABETIC FOOT ULCER TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. DIABETIC FOOT ULCER TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. DIABETIC FOOT ULCER TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DIABETIC FOOT ULCER TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DIABETIC FOOT ULCER TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ANTIBIOTIC MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY SKIN GRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY NEGATIVE PRESSURE WOUND THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULTRASOUND THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ALGINATE DRESSINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY FILM DRESSING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY FOAM DRESSINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY HYDROCOLLOID DRESSINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY HYDROFIBER DRESSINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY HYDROGEL DRESSINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY SURGICAL DRESSINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ISCHEMIC ULCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY NEURO-ISCHEMIC ULCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY NEUROPATHIC ULCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY AMBULATORY IMAGING CENTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 283. DIABETIC FOOT ULCER TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 284. DIABETIC FOOT ULCER TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023